United Kingdom · Question · Written question
UIN 27176
Liothyronine
Introduced
20 May 2024
Last action
23 May 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
23 May 2024
Summary
To ask the Secretary of State for Health and Social Care, whether her Department has made a comparative estimate of the cost of Liothyronine in (a) the UK and (b) other countries.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
20 May 2024
Written question
To ask the Secretary of State for Health and Social Care, whether her Department has made a comparative estimate of the cost of Liothyronine in (a) the UK and (b) other countries.
Source: Commons
23 May 2024
Answer
Liothyronine is marketed as a generic medicine. For generic medicines, we rely on competition to keep prices down. This works well for the most part, as evidence shows we have amongst the lowest prices in Europe for generic medicines. The system also mean...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-05-20/27176
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1719438
- uk · wq-1719438 · source updated 23 May 2024